In this presentation, Prof. Do Young Kim reviews the results of the APAC expert consensus study on the utilization of PIVKA-II in the surveillance and monitoring of hepatocellular carcinoma in APAC. The objective of this study is to discuss the clinical usefulness and value of PIVKA-II in APAC for the surveillance and treatment monitoring of HCC, its benefits and limitations, and further steps required to improve its utility. His results were also presented during APASL 2022….
Cancer Type: Liver
APASL 2022 Seoul
The liver cancer landscape has been undergoing a period of rapid transformation. From early detection of HCC using new biomarkers, to new immunotherapy treatment options. Watch the APASL 2022 webinars to hear experts share updates in the diagnosis and testing, and treatment of HCC. …
Global HCC Expert Series
Join our experts for a series of on-demand webinars, focused on clinical insights and knowledge from the fields of oncology, hepatology, interventional radiology, and surgery, to navigate the evolving HCC treatment paradigm. Register now to access the HCC Virtual Campus….
APPLE 2021 – Biomarker In HCC Surveillance And Treatment: The New Evidence On The Horizon
Join the webinar to hear speakers Prof. Henry Chan and Prof. Hui Chuan Sun as they discuss the use of PIVKA-II and GAAD score as promising tools for HCC surveillance, and the value of AFP and PIVKA-II in HCC treatment monitoring. …
APASL 2021 – The First Line Treatment in Unresectable HCC: From Evidence To Practice
Join the webinar to hear speakers Prof. Henry Chan, and Assoc. Prof. Teerha Piratvisuth as they discuss the clinical usefulness of PIVKA-II in HCC surveillance, as well as the evidence based practice of first line treatments in unresectable HCC. …
Liver Disease in Asia Pacific: Insights from Prof Pierce Chow
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment….